Evidence map›Paper›PMID 42676732›Full record

ArticleFrontiers in health services2026

Healthcare utilization patterns and medication burden in post-COVID syndrome: a cross-sectional analysis reveals four phenotypes.

Jens Hamberger, Linda Kraus, Karin Meissner, Thilo Hinterberger, Thomas Loew, Oliver Schoeffski, Harald Gündel, Steffen Walter, Marc N Jarczok, Katja Weimer

Abstract read
In one paragraph

Article in Frontiers in health services, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jens HambergerDepartment of Psychosomatic Medicine, University Clinic Regensburg, Regensburg, Germany.
Linda KrausDepartment of Psychosomatic Medicine and Psychotherapy, Ulm University Medical Center, Ulm, Germany.
Karin MeissnerDepartment of Applied Natural Sciences and Health, Coburg University of Applied Sciences and Arts, Coburg, Germany.
Thilo HinterbergerDepartment of Psychosomatic Medicine, University Clinic Regensburg, Regensburg, Germany.
Thomas LoewDepartment of Psychosomatic Medicine, University Clinic Regensburg, Regensburg, Germany.
Oliver SchoeffskiSchool of Business and Economics, Chair of Health Care Management, Friedrich-Alexander University of Erlangen-Nuremberg, Nuremberg, Germany.
Harald GündelDepartment of Psychosomatic Medicine and Psychotherapy, Ulm University Medical Center, Ulm, Germany.
Steffen WalterDepartment of Psychosomatic Medicine and Psychotherapy, Ulm University Medical Center, Ulm, Germany.
Marc N JarczokDepartment of Psychosomatic Medicine and Psychotherapy, Ulm University Medical Center, Ulm, Germany.
Katja WeimerDepartment of Psychosomatic Medicine and Psychotherapy, Ulm University Medical Center, Ulm, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-COVID syndrome has emerged as a major public health challenge, yet comprehensive characterization of healthcare utilization patterns and medication burden within single cohorts remains limited. This cross-sectional analysis examined baseline data from 76 patients (49 ± 12 years, 62% female) enrolled in a randomized trial of psychosomatic treatment interventions for functional post-COVID syndrome. Participants completed the Health Care Utilization Questionnaire (HCU) assessing physician visits, hospitalizations, alternative healing methods, and other healthcare services over the preceding 12 months. Medication and other preparation (MOP) use was systematically documented and classified using the Anatomical Therapeutic Chemical (ATC) classification system. K-means clustering identified distinct patient phenotypes, and correlations between MOP count and healthcare utilization were examined using Spearman correlation coefficients. Healthcare utilization was universal, with 100% of participants engaging with healthcare services and a mean of 43.5 contacts per year. Medication burden was substantial, with 85.5% taking at least one medication, a mean of 4.57 medications per patient, and polypharmacy (≥5 MOP, all types) present in 39.5% of the cohort (46.1% of patients with any MOP). K-means clustering identified four distinct patient phenotypes: Low Utilizers (64.5%,

Indexed as

healthcare costshealthcare utilizationlong Covidmedication burdenpatient clusteringpolypharmacypost-COVID syndromepsychosomatic medicine

Identifiers

PMID42676732
PMCPMC13527022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.